BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 3414094)

  • 1. [Treatment of patients with postmenopausal osteoporosis and steroid-induced osteoporosis with the preparation Rocaltrol (1,25/OH/2 vitamin D3)].
    Koev D; Todorova S; Diankov L; Khristova D; Tsachev K
    Vutr Boles; 1988; 27(2):117-22. PubMed ID: 3414094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and management of osteoporosis: consensus statements from the Scientific Advisory Board of the Osteoporosis Society of Canada. 8. Vitamin D metabolites and analogs in the treatment of osteoporosis.
    Jones G; Hogan DB; Yendt E; Hanley DA
    CMAJ; 1996 Oct; 155(7):955-61. PubMed ID: 8837546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Comparative evaluation of the effectiveness of vitamin D3 preparations (1-alpha-hydroxy- and 1-alpha,25-dihydroxycholecalciferol in various forms of osteoporosis and osteomalacia].
    Zarubina NA; Rozhinskaia LIa; Bukhman AI; Dorokhova II; Konnova EV
    Probl Endokrinol (Mosk); 1989; 35(3):15-9. PubMed ID: 2762260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, biochemical and histological results of a double-blind trial with 1,25-dihydroxyvitamin D3, estradiol and placebo in post-menopausal osteoporosis.
    Caniggia A; Delling G; Nuti R; Lorè F; Vattimo A
    Acta Vitaminol Enzymol; 1984; 6(2):117-28. PubMed ID: 6388277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The vitamin D endocrine system, calcium metabolism, and osteoporosis.
    Slovik DM
    Spec Top Endocrinol Metab; 1983; 5():83-148. PubMed ID: 6367121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Efficiency of calcium and vitamin D3 in the treatment of steroid osteoporosis in patients with hormone dependent bronchial asthma].
    Ememl'ianov AV; Shevelev SE; Murzin BA; Amosov VI
    Ter Arkh; 1999; 71(11):68-9. PubMed ID: 10626343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone mineralometry in post-menopausal osteoporosis].
    Nuti R; Righi G; Turchetti V
    Minerva Med; 1983 Jun; 74(27):1589-94. PubMed ID: 6687928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of vitamin D, its metabolites, and analogs in the management of osteoporosis.
    Bikle DD
    Rheum Dis Clin North Am; 1994 Aug; 20(3):759-75. PubMed ID: 7984788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Corticoid-induced osteoporosis. Pathogenesis, diagnosis and treatment].
    Negri AL; Spivacow FR; Zanchetta JR
    Medicina (B Aires); 1992; 52(3):257-64. PubMed ID: 1342693
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of calcitriol on bone mineral density in premenopausal Chinese women taking chronic steroid therapy. A randomized, double blind, placebo controlled study.
    Lambrinoudaki I; Chan DT; Lau CS; Wong RW; Yeung SS; Kung AW
    J Rheumatol; 2000 Jul; 27(7):1759-65. PubMed ID: 10914864
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Calcitriol and alendronate combination treatment in menopausal women with low bone mass.
    Malavolta N; Zanardi M; Veronesi M; Ripamonti C; Gnudi S
    Int J Tissue React; 1999; 21(2):51-9. PubMed ID: 10568224
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
    Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
    Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Steroid osteoporosis].
    Kocián J
    Vnitr Lek; 1998 Feb; 44(2):86-92. PubMed ID: 9820082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in calcium balance in normal subjects and patients with osteoporosis and osteomalacia treated with vitamin D 2].
    Terlizzi N; Martiradonna A; Carrozzo M
    Reumatismo; 1977; 29(2-3):191-5. PubMed ID: 309161
    [No Abstract]   [Full Text] [Related]  

  • 18. [Idiopathic osteoporosis at an early age].
    Baleva R; Diankov L
    Vutr Boles; 1977; 16(3):96-101. PubMed ID: 898935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes in phospho-calcic metabolism in osteoporosis, osteomalacia and osteoporomalacia].
    Carrozzo M; Terlizzi N; D'Amore M
    Reumatismo; 1975; 27(1):66-71. PubMed ID: 1233653
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of corticosteroid induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital.
    Smith MD; Cheah SP; Taylor K; Ahern MJ
    J Rheumatol; 2001 Mar; 28(3):566-70. PubMed ID: 11296960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.